Calidi Biotherapeutics, Inc. Current Income Tax Expense (Benefit)
Calidi Biotherapeutics, Inc. (CLDI) reported Current Income Tax Expense (Benefit) of $15.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-27.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentIncomeTaxExpenseBenefit · last filed 2026-03-27
- Calidi Biotherapeutics, Inc. current income tax expense (benefit) for fiscal 2025 was $15.00K, a 7.14% increase from fiscal 2024.
- Calidi Biotherapeutics, Inc. current income tax expense (benefit) for fiscal 2024 was $14.00K, a 12.50% decline from fiscal 2023.
- Calidi Biotherapeutics, Inc. current income tax expense (benefit) for fiscal 2023 was $16.00K, a 45.45% increase from fiscal 2022.
- Calidi Biotherapeutics, Inc. current income tax expense (benefit) for fiscal 2022 was $11.00K.
| Period end | Current Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | $15.00K 10-K · filed 2026-03-27 |
| 2024-12-31 | $14.00K 10-K · filed 2026-03-27 |
| 2023-12-31 | $16.00K 10-K · filed 2025-03-31 |
| 2022-12-31 | $11.00K 10-K · filed 2024-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |